Alpha Teknova, Inc. (NASDAQ:TKNO) Short Interest Up 54.3% in February

Alpha Teknova, Inc. (NASDAQ:TKNO) was the recipient of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 964,000 shares, an increase of 54.3% from the January 31st total of 624,800 shares. Approximately 9.1% of the shares of the company are sold short. Based on an average daily volume of 278,000 shares, the days-to-cover ratio is currently 3.5 days.

Analyst Upgrades and Downgrades

Separately, Craig Hallum initiated coverage on shares of Alpha Teknova in a research report on Monday, February 10th. They issued a “buy” rating and a $12.00 price target on the stock.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in TKNO. Invesco Ltd. bought a new stake in shares of Alpha Teknova in the fourth quarter valued at approximately $9,236,000. Point72 Asset Management L.P. bought a new stake in Alpha Teknova in the 3rd quarter valued at $1,483,000. Susquehanna International Group LLP grew its position in Alpha Teknova by 472.5% in the 4th quarter. Susquehanna International Group LLP now owns 209,409 shares of the company’s stock worth $1,749,000 after purchasing an additional 172,828 shares during the last quarter. 683 Capital Management LLC acquired a new position in shares of Alpha Teknova during the fourth quarter valued at about $744,000. Finally, Raymond James Financial Inc. bought a new stake in shares of Alpha Teknova in the fourth quarter valued at about $716,000. 13.81% of the stock is owned by institutional investors.

Alpha Teknova Stock Performance

Shares of Alpha Teknova stock traded down $0.64 during trading on Monday, reaching $5.86. The company’s stock had a trading volume of 408,709 shares, compared to its average volume of 277,716. Alpha Teknova has a one year low of $1.16 and a one year high of $10.37. The company has a debt-to-equity ratio of 0.12, a quick ratio of 3.94 and a current ratio of 4.73. The firm has a market cap of $312.38 million, a price-to-earnings ratio of -7.92 and a beta of 0.34. The business’s fifty day moving average price is $8.32 and its 200-day moving average price is $6.88.

About Alpha Teknova

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.